18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
Aim of the present analysis is to investigate the biodistribution and pharmacokinetics of the recently clinically introduced radioligand 18F-PSMA-1007 in patients with biochemical recurrence or progression of prostate cancer (PC) by means of multiparametric (dynamic and whole-body) PET/CT.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2019, Jahrgang: 47, Heft: 3, Pages: 592-602 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-019-04569-0 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-019-04569-0 |
| Verfasserangaben: | Christos Sachpekidis, A. Afshar-Oromieh, K. Kopka, D.S. Strauss, L. Pan, U. Haberkorn, A. Dimitrakopoulou-Strauss |
| Zusammenfassung: | Aim of the present analysis is to investigate the biodistribution and pharmacokinetics of the recently clinically introduced radioligand 18F-PSMA-1007 in patients with biochemical recurrence or progression of prostate cancer (PC) by means of multiparametric (dynamic and whole-body) PET/CT. |
|---|---|
| Beschreibung: | Im Titel ist die Zahl 18 hochgestellt Published online: 14 November 2019 Gesehen am 02.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-019-04569-0 |